Genes such as AMOT, PDE11A, TYMS, TMEM98, and PTGS2 demonstrated substantial diagnostic potential for identifying NAFLD patients at risk of AF. This evidence concerns the gene PDE11A and metabolic dysfunction-associated steatotic liver disease.